These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30399464)

  • 1. Single and combined effects of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events: A prospective cohort study.
    Saely CH; Schindewolf M; Zanolin D; Heinzle CF; Vonbank A; Silbernagel G; Leiherer A; Drexel H; Baumgartner I
    Atherosclerosis; 2018 Dec; 279():32-37. PubMed ID: 30399464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease.
    Sprenger L; Mader A; Larcher B; Mächler M; Vonbank A; Zanolin-Purin D; Leiherer A; Muendlein A; Drexel H; Saely CH
    BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34782334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
    Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus.
    Eleftheriadou I; Grigoropoulou P; Kokkinos A; Mourouzis I; Perrea D; Katsilambros N; Sfikakis PP; Tentolouris N
    J Diabetes Complications; 2017 Mar; 31(3):599-604. PubMed ID: 27899247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Bonadia N; Bruno P; Angelini F; Di Stasi C; Contegiacomo A; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Sep; 19(1):147. PubMed ID: 32977814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.
    Joosten MM; Pai JK; Bertoia ML; Rimm EB; Spiegelman D; Mittleman MA; Mukamal KJ
    JAMA; 2012 Oct; 308(16):1660-7. PubMed ID: 23093164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.
    Yubero-Serrano EM; Alcalá-Diaz JF; Gutierrez-Mariscal FM; Arenas-de Larriva AP; Peña-Orihuela PJ; Blanco-Rojo R; Martinez-Botas J; Torres-Peña JD; Perez-Martinez P; Ordovas JM; Delgado-Lista J; Gómez-Coronado D; Lopez-Miranda J
    Cardiovasc Diabetol; 2021 Mar; 20(1):72. PubMed ID: 33766036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
    King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
    Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes.
    Batinic K; Höbaus C; Grujicic M; Steffan A; Jelic F; Lorant D; Hörtenhuber T; Hoellerl F; Brix JM; Schernthaner G; Koppensteiner R; Schernthaner GH
    Atherosclerosis; 2012 Jun; 222(2):557-63. PubMed ID: 22572101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of peripheral artery disease according to a healthy lifestyle score: The PREDIMED study.
    López-Laguna N; Martínez-González MA; Toledo E; Babio N; Sorlí JV; Ros E; Muñoz MÁ; Estruch R; Lapetra J; Muñoz-Bravo C; Fiol M; Serra-Majem L; Pintó X; González JI; Fitó M; Basora J; Arós F; Ruiz-Canela M
    Atherosclerosis; 2018 Aug; 275():133-140. PubMed ID: 29902701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Visit-to-Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes.
    Hsu JC; Yang YY; Chuang SL; Huang KC; Lee JK; Lin LY
    J Am Heart Assoc; 2023 Feb; 12(3):e025438. PubMed ID: 36695326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes.
    Mueller T; Hinterreiter F; Luft C; Poelz W; Haltmayer M; Dieplinger B
    J Vasc Surg; 2014 May; 59(5):1291-9. PubMed ID: 24393280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
    Samman Tahhan A; Hayek SS; Sandesara P; Hajjari J; Hammadah M; O'Neal WT; Kelli HM; Alkhoder A; Ghasemzadeh N; Ko YA; Aida H; Gafeer MM; Abdelhadi N; Mohammed KH; Patel K; Arya S; Reiser J; Vaccarino V; Sperling L; Quyyumi A
    Atherosclerosis; 2017 Sep; 264():108-114. PubMed ID: 28728756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and homocystein were risk factor for peripheral arterial disease in elderly with type 2 diabetes mellitus.
    Kuswardhani RA; Suastika K
    Acta Med Indones; 2010 Apr; 42(2):94-9. PubMed ID: 20513934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin, type 2 diabetes and cardiovascular risk.
    Lindberg S; Jensen JS; Bjerre M; Pedersen SH; Frystyk J; Flyvbjerg A; Galatius S; Jeppesen J; Mogelvang R
    Eur J Prev Cardiol; 2015 Mar; 22(3):276-83. PubMed ID: 24265290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Legumain Is Associated with Peripheral Artery Disease in Patients with Type 2 Diabetes.
    Wei W; Chen S; Huang J; Tong Y; Zhang J; Qiu X; Zhang W; Chen H; Huang R; Cai J; Tu M
    J Diabetes Res; 2021; 2021():5651469. PubMed ID: 34961842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
    Gorter PM; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2007 Dec; 24(12):1352-60. PubMed ID: 18042079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell.
    Liao YF; Feng Y; Chen LL; Zeng TS; Yu F; Hu LJ
    J Diabetes Complications; 2014; 28(2):214-8. PubMed ID: 24332936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes.
    Feng B; Xu G; Sun K; Duan K; Shi B; Zhang N
    Cardiovasc Diabetol; 2020 Nov; 19(1):194. PubMed ID: 33222686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation between apolipoprotein E (APOE) genotype and peripheral artery disease in patients at high risk for cardiovascular disease.
    Koopal C; Geerlings MI; Muller M; de Borst GJ; Algra A; van der Graaf Y; Visseren FL;
    Atherosclerosis; 2016 Mar; 246():187-92. PubMed ID: 26800308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.